San Diego, CA, United States of America

Ying-Chi Lin


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ying-Chi Lin in Nucleic Acid Amplification

Introduction

Ying-Chi Lin is a notable inventor based in San Diego, CA, who has made significant contributions to the field of nucleic acid amplification. With a total of 2 patents, his work focuses on innovative methods that enhance the efficiency and effectiveness of nucleic acid amplification techniques.

Latest Patents

Ying-Chi Lin's latest patents include groundbreaking technologies such as "Nested oligonucleotides containing a hairpin for nucleic acid amplification." This invention provides engineered templates that allow Single Primer Amplification (SPA) to amplify target sequences, which can be cloned into expression vehicles for creating libraries of polypeptides or proteins, including antibody libraries. Another significant patent is "Engineered templates and their use in single primer amplification," which outlines methods for amplifying nucleic acids through a series of precise steps involving primer annealing and polynucleotide synthesis.

Career Highlights

Ying-Chi Lin is currently employed at Alexion Pharmaceuticals, Inc., where he continues to develop innovative solutions in the biotechnology sector. His work has the potential to impact various applications in medical research and therapeutic development.

Collaborations

Some of his notable coworkers include Toshiaki Maruyama and Shana Frederickson, who contribute to the collaborative environment that fosters innovation at Alexion Pharmaceuticals.

Conclusion

Ying-Chi Lin's contributions to nucleic acid amplification represent a significant advancement in biotechnology, showcasing his expertise and innovative spirit in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…